BAX and cancer: The involvement of p53/Bax signaling and downregulation of cancer markers (such as Bcl-2 heterogeneous nuclear ribonucleoprotein A2/B1, prohibitin, and annexin) has been shown to be involved in eurycomanone-induced apoptosis [40, 42] and anchorage-independent growth inhibition [8].